Physician profile
Joel Kravitz
NPI 1548237589
$1,513.10
in general payments reported to CMS, 2019-2025
10 companies · $397 in 2025
The $397 reported for 2025 was more than what 91% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $363 · 2024: $628 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $549.96 | 2022-2024 | Andexxa |
| Mindray Ds USA, INC. | $297.61 | 2024 | Te X, Te7 Max |
| Chiesi USA, INC. | $213.04 | 2025 | Cleviprex |
| Abbvie INC. | $163.42 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $124.60 | 2023 | Dvr Anatomic Kickstand |
| Octapharma USA, INC. | $100.00 | 2025 | Balfaxar |
| Vapotherm INC | $20.06 | 2023 | Vapotherm |
| Fisher & Paykel Healthcare INC | $15.88 | 2024 | Fisher & Paykel Healthcare |
| Pfizer INC. | $14.37 | 2025 | |
| Gilead Sciences, INC. | $14.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Kravitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.